It is plausible that tau phosphorylated at S202 and S262 can bind to fyn or influence fyn expression or function under basal conditions, but at late stages of AD, tau becomes increasingly phosphorylated at other residues which could alter the its subcellular localisation or conformation and cause the loss of tau-fyn binding. The gene discussed is MAPT; the disease is Alzheimer disease.